Cargando…
Therapeutic Drug Monitoring of Posaconazole: an Update
Posaconazole is a second-generation triazole agent with a potent and broad antifungal activity. In addition to the oral suspension, a delayed-release tablet and intravenous formulation with improved pharmacokinetic properties have been introduced recently. Due to the large interindividual and intrai...
Autores principales: | Dekkers, Bart G. J., Bakker, Martijn, van der Elst, Kim C. M., Sturkenboom, Marieke G. G., Veringa, Anette, Span, Lambert F. R., Alffenaar, Jan-Willem C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896980/ https://www.ncbi.nlm.nih.gov/pubmed/27358662 http://dx.doi.org/10.1007/s12281-016-0255-4 |
Ejemplares similares
-
Next-Generation Sequencing in the Mycology Lab
por: Zoll, Jan, et al.
Publicado: (2016) -
Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?
por: Prattes, Juergen, et al.
Publicado: (2016) -
Progress in the Diagnosis of Invasive Fungal Disease in Children
por: Warris, Adilia, et al.
Publicado: (2017) -
Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
por: Märtson, Anne‐Grete, et al.
Publicado: (2019) -
Recent update in diagnosis and treatment of human pythiosis
por: Chitasombat, Maria Nina, et al.
Publicado: (2020)